Compare ARK Genomic Revolution ETF (ARKG) vs Elastic NV (ESTC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Elastic NV — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Elastic NV trades at $59.95 (market cap $6.26B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Elastic NV nearer its low. Which is the better fit depends on your goals.
| ARKG | ESTC | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $94.47 |
52-Week Low | $23.09 | $43.30 |
Market Cap | — | $6.26B |
Enterprise Value | — | $5.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Elastic (ESTC) trades at $60.24, down 2.93% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $72.80. The company shows strong revenue growth, improving profitability into 2026, and consistent earnings beats, while recent news highlights leadership in security and observability markets.
The stock presents a growth opportunity with robust fundamentals and positive analyst sentiment, though risks include high valuation multiples, ongoing legal scrutiny, and competitive pressures in the software sector that could impact future performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Elastic NV
Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →
